N | % | Median (min–max) | Mean (SD) | |
Age | 45 (25–75) | |||
Body mass index (kg/m2) | 23.2 (15.2–46.1) | 25.3 (6.3) | ||
Overweight (≥25 kg/m2) | 28 | 35 | ||
Previous conization | ||||
No | 62 | 77 | ||
Yes | 18 | 23 | ||
Histological type | ||||
Squamous cell carcinoma | 64 | 80 | ||
Adenocarcinoma | 13 | 16 | ||
Both | 3 | 4 | ||
FIGO stage | ||||
IB1 | 72 | 90 | ||
IIB | 6 | 8 | ||
IIA | 2 | 3 | ||
Tumor differentiation | ||||
Poorly differentiated | 23 | 31 | ||
Moderately differentiated | 16 | 22 | ||
Well differentiated | 35 | 47 | ||
LVSI | ||||
No | 64 | 89 | ||
Yes | 8 | 11 | ||
Clinical size (cm) | 2.5 (0–4) | 2.3 (1.1) | ||
MRI size (cm) | 3 (0–4) | 2.7 (0.9) |
FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space involvement; MRI, magnetic resonance imaging;SD, standard deviation.